Medicare AdvantageCoverageMedium impact
Cryoablation - Medicare Advantage (Revised)
Humana·FL, AL, GA, TN, NC, SC, VA, WV · Dermatology, Urology, Oncology +2 more·Medicare Advantage
Effective date
Aug 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage has updated its cryoablation coverage policy, effective August 1, 2025, establishing specific medical necessity criteria for various conditions including skin cancers, prostate cancer, cervical neoplasia, and liver tumors. The policy provides detailed coverage determinations and follows CMS guidelines with jurisdiction-specific LCD requirements.
Action Required
Before August 1, 2025: Review and update prior authorization processes for cryoablation procedures to ensure compliance with new medical necessity criteria. Billing team must verify that documentation supports specific coverage requirements for basal cell carcinoma, squamous cell carcinoma, Kaposi sarcoma, cervical intraepithelial neoplasia, prostate cancer, and liver tumors. Update encounter forms to include required criteria checklists for providers performing cryoablation procedures.